Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cholesterol and lipid disorder guidelines AND hydroxymethylglutaryl-coa reductase inhibitors:

Search results

Items: 1 to 20 of 857

1.

Treatment of Cholesterol in 2017.

Krumholz HM.

JAMA. 2017 Aug 1;318(5):417-418. doi: 10.1001/jama.2017.6753. No abstract available.

PMID:
28738130
2.

Inconsistent Guideline Recommendations for Cardiovascular Prevention and the Debate About Zeroing in on and Zeroing LDL-C Levels With PCSK9 Inhibitors.

Ioannidis JPA.

JAMA. 2017 Aug 1;318(5):419-420. doi: 10.1001/jama.2017.6765. No abstract available.

PMID:
28738115
3.

Utility of 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines in HIV-Infected Adults With Carotid Atherosclerosis.

Phan BAP, Weigel B, Ma Y, Scherzer R, Li D, Hur S, Kalapus SC, Deeks S, Hsue P.

Circ Cardiovasc Imaging. 2017 Jul;10(7). pii: e005995. doi: 10.1161/CIRCIMAGING.116.005995.

4.

Hypercholesterolaemia and vascular dementia.

Appleton JP, Scutt P, Sprigg N, Bath PM.

Clin Sci (Lond). 2017 Jun 30;131(14):1561-1578. doi: 10.1042/CS20160382. Print 2017 Jul 15. Review.

PMID:
28667059
5.

A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol.

Ballantyne CM, Shah S, Sapre A, Ashraf TB, Tobias SC, Sahin T, Ye P, Dong Y, Sheu WH, Kang DH, Ferreira Rossi PR, Moiseeva Y, Briones IR, Johnson-Levonas AO, Mitchel YB.

Am J Cardiol. 2017 Aug 15;120(4):569-576. doi: 10.1016/j.amjcard.2017.03.255. Epub 2017 Apr 12.

6.

Prevalence of Elevated Cardiovascular Risks in Young Adults: A Cross-sectional Analysis of National Health and Nutrition Examination Surveys.

Patel KK, Taksler GB, Hu B, Rothberg MB.

Ann Intern Med. 2017 Jun 20;166(12):876-882. doi: 10.7326/M16-2052. Epub 2017 May 16.

PMID:
28505660
7.

[2016 European Society of Cardiology guidelines for the management of dyslipidemias].

Ferrières J.

Presse Med. 2017 Jul - Aug;46(7-8 Pt 1):688-696. doi: 10.1016/j.lpm.2017.03.008. Epub 2017 May 10. French.

PMID:
28502376
8.

Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study.

Lerman JB, Joshi AA, Chaturvedi A, Aberra TM, Dey AK, Rodante JA, Salahuddin T, Chung JH, Rana A, Teague HL, Wu JJ, Playford MP, Lockshin BA, Chen MY, Sandfort V, Bluemke DA, Mehta NN.

Circulation. 2017 Jul 18;136(3):263-276. doi: 10.1161/CIRCULATIONAHA.116.026859. Epub 2017 May 8.

PMID:
28483812
9.

2017 Taiwan lipid guidelines for high risk patients.

Li YH, Ueng KC, Jeng JS, Charng MJ, Lin TH, Chien KL, Wang CY, Chao TH, Liu PY, Su CH, Chien SC, Liou CW, Tang SC, Lee CC, Yu TY, Chen JW, Wu CC, Yeh HI; Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients.

J Formos Med Assoc. 2017 Apr;116(4):217-248. doi: 10.1016/j.jfma.2016.11.013. Epub 2017 Feb 24. Review.

10.

Cholesterol Screening and Treatment Practices and Preferences: A Survey of United States Pediatricians.

de Ferranti SD, Rodday AM, Parsons SK, Cull WL, O'Connor KG, Daniels SR, Leslie LK.

J Pediatr. 2017 Jun;185:99-105.e2. doi: 10.1016/j.jpeds.2016.12.078. Epub 2017 Feb 13.

PMID:
28209292
11.

Statins, Ezetimibe, and Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors to Reduce Low-Density Lipoprotein Cholesterol and Cardiovascular Events.

O'Keefe JH, DiNicolantonio JJ, Lavie CJ.

Am J Cardiol. 2017 Feb 15;119(4):565-571. doi: 10.1016/j.amjcard.2016.11.001. Epub 2016 Nov 23.

PMID:
28081940
12.

[Are therapeutic LDL goals justified? Controversies between the European and American guidelines].

Bertomeu-Martínez V.

Medwave. 2016 Dec 30;16(Suppl4):e6825. doi: 10.5867/medwave.2016.6825. Review. Spanish.

PMID:
28055995
13.

Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia.

Benes LB, Bassi NS, Davidson MH.

Vasc Health Risk Manag. 2016 Dec 12;12:481-490. doi: 10.2147/VHRM.S58149. eCollection 2016. Review.

14.

A Review of Clinical Practice Guidelines for the Management of Hypertriglyceridemia: A Focus on High Dose Omega-3 Fatty Acids.

Karalis DG.

Adv Ther. 2017 Feb;34(2):300-323. doi: 10.1007/s12325-016-0462-y. Epub 2016 Dec 15. Review.

15.

Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients with Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol.

Ballantyne CM, Shah S, Kher U, Hunter JA, Gill GG, Cressman MD, Ashraf TB, Johnson-Levonas AO, Mitchel YB.

Am J Cardiol. 2017 Feb 1;119(3):388-396. doi: 10.1016/j.amjcard.2016.10.032. Epub 2016 Nov 1.

16.

Under-prescription of statins in patients with non-alcoholic fatty liver disease.

Del Ben M, Baratta F, Polimeni L, Pastori D, Loffredo L, Averna M, Violi F, Angelico F.

Nutr Metab Cardiovasc Dis. 2017 Feb;27(2):161-167. doi: 10.1016/j.numecd.2016.09.011. Epub 2016 Sep 28.

PMID:
27914698
17.

New concepts in the management of dyslipidaemiaa.

Gencer B, Rodondi N, Mach F.

Swiss Med Wkly. 2016 Nov 12;146:w14378. doi: 10.4414/smw.2016.14378. eCollection 2016.

18.

2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult.

Anderson TJ, Grégoire J, Pearson GJ, Barry AR, Couture P, Dawes M, Francis GA, Genest J Jr, Grover S, Gupta M, Hegele RA, Lau DC, Leiter LA, Lonn E, Mancini GB, McPherson R, Ngui D, Poirier P, Sievenpiper JL, Stone JA, Thanassoulis G, Ward R.

Can J Cardiol. 2016 Nov;32(11):1263-1282. doi: 10.1016/j.cjca.2016.07.510. Epub 2016 Jul 25. Review.

PMID:
27712954
19.

The effect of the intensity of lipid-lowering medications on the LDL cholesterol treatment goals of Asian patients with dyslipidaemia in primary care.

Tan NC, Goh CC, Goh SC, Koh YL, Koh KH.

J Clin Pharm Ther. 2016 Dec;41(6):677-683. doi: 10.1111/jcpt.12447. Epub 2016 Sep 19.

PMID:
27641514
20.

Challenges in Oral Lipid-lowering Therapy: Position Document of the Spanish Society of Cardiology.

Anguita Sánchez M, Castro Conde A, Cordero Fort A, García-Moll Marimón X, Gómez Doblas JJ, González-Juanatey JR, Lidón Corbi RM, López-Sendón JL, Mostaza Prieto J, Rodríguez Padial L.

Rev Esp Cardiol (Engl Ed). 2016 Nov;69(11):1083-1087. doi: 10.1016/j.rec.2016.05.033. Epub 2016 Sep 16. English, Spanish.

PMID:
27650859

Supplemental Content

Loading ...
Support Center